<DOC>
	<DOCNO>NCT01858636</DOCNO>
	<brief_summary>To characterize clinical outcome Angio-Seal VIP St. Jude Medical ( SJM ) collagen collection device/procedure-related major vascular complication time hemostasis .</brief_summary>
	<brief_title>Post-Market Study St. Jude Medical Angio-Seal™ V-Twist Integrated Platform ( VIP ) Vascular Closure Device</brief_title>
	<detailed_description />
	<criteria>Patient require closure femoral artery puncture result arterial access procedure . Patient ≥18 year age . Patient willing provide write informed consent prior study device use . Patient willing able adhere data collection followup requirement . Patient participate another clinical trial potential impact hemostasis . Patient active groin infection systemic infection . Patient undergone vascular access procedure within past 90 day . Patient previously enrol study . ( For patient undergo multiple intervention within timeframe 90 day , initial procedure may constitute study enrollment . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>